alexion pharmaceuticals inc
(ALXN:Consolidated Issue Listed on NASDAQ Global Select )
Camille L. Bedrosian M.D.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 3 different industries.|
Dr. Camille L. Bedrosian, M.D., served as Chief Medical Officer and Senior Vice President of Alexion Pharmaceuticals, Inc. since May 2008. Dr. Bedrosian has more than 25 years of medical practice, research and drug development experience. Dr. Bedrosian has global responsibility for aspects of clinical research, such as clinical operations, clinical data management, medical affairs and pharmacovigilance. She served as Chief Medical Officer and Vice President of Ariad ...
352 Knotter DrivePhone: 203-272-2596
Cheshire, Connecticut 06410
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
Radcliffe Institute for Advanced Study
Harvard Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma Inc.
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Werner Lanthaler MBA,MPA||Chief Executive Officer and Member of Management Board|
|Aijaz Tobaccowalla||Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee|
|Michael L. Babich||Chief Executive Officer, President and Director|
INSYS Therapeutics, Inc.
|$889.2K||Compensation as of Fiscal Year 2014.|